Cancer Research includes companies working on scientific research aimed at understanding the causes, prevention, diagnosis, treatment, and potential cures for cancer. It includes many disciplines, from biology and genetics, to clinical trials and drug development, with the ultimate goal of improving cancer care and outcomes. Cancer research companies are developing life-saving treatments and diagnostics for a growing market in high demand. These companies constantly innovate, have a global reach, and form important strategic partnerships, which makes them appealing to investors looking for profits and supporting health progress.
Merck's Keytruda Gains FDA Priority Review for Head and Neck Cancer Treatment
Wall Street Today: Market Had Us in the First Half, Not Gonna Lie
The Stocks That 'Matter the Most' to Hedge Funds – Goldman Sachs
Gilead Sciences Unusual Options Activity
NHS England's Transition From Biogen's Drug To Sandoz's Biosimilar Sparks Alarm As Multiple Sclerosis Patients Report Severe Effects
'Pfizer Names Former FDA Director Patrizia Cavazzoni As Chief Medical Officer' - Reuters News